Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | OBIOOrchestra BioMed Holdings, Inc.FY2025 · Dec |
|---|---|
| Revenue | $33.48M |
| Revenue, yoy | +1,169.2% |
| Net income | $52.70M |
| Net income, yoy | +13.6% |
| Net margin | -157.4% |
| Free cash flow | $49.45M |
| FCF margin | -147.7% |
| EPS, diluted | $1.11 |
Add another company.